A hot biotech that may be the next Genentech By: CNBC.com News May 12, 2015 at 07:00 AM EDT This company has raised $1 billion to develop the Holy Grail in drugs: having the body's own cells churn out proteins to fight disease. Read More >> Related Stocks: AbbVie Alexion Pharmaceuticals Alnylam Pharmaceuticals Astrazeneca Plc ADR Merck & Co Regulus Therapeutics